Vanda Pharmaceuticals, Inc. (VNDA)
6.14
+0.75
(+13.91%)
USD |
NASDAQ |
Dec 08, 16:00
6.17
+0.03
(+0.49%)
After-Hours: 05:33
Vanda Pharmaceuticals Total Liabilities (Quarterly): 135.14M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| ADMA Biologics, Inc. | 137.50M |
| Aldeyra Therapeutics, Inc. | 28.56M |
| Exelixis, Inc. | 662.85M |
| Anavex Life Sciences Corp. | 8.946M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 601.14M |
| Shareholders Equity (Quarterly) | 466.00M |
| Debt to Equity Ratio | 0.0234 |
| Current Ratio | 3.118 |
| Net Debt Paydown Yield | -0.17% |